Proceedings · Session S-428 · filed November 20, 2026

Research InfrastructureSession paper

Ghana Opens Vaccine R&D and DNA Labs at Noguchi Institute

President Mahama opens mRNA, protein expression and DNA laboratories at Noguchi Institute after the August 2025 crash forced samples to South Africa; US$1 billion backs pharma hubs.

By Amara Osei3 min read699 words

Summary

  • President Mahama inaugurated Vaccine R&D and DNA laboratories at the Noguchi Memorial Institute, University of Ghana, Legon.
  • The DNA lab responds to the August 6, 2025 military helicopter crash that killed eight people and required DNA analysis in South Africa.
  • The vaccine facilities include an mRNA Expression Laboratory and a Protein Expression Laboratory.
  • Government has allocated US$1 billion to the pharmaceutical sector under the Seventh Pillar of the New Economy Programme.
  • Biomanufacturing hubs are planned in the Eastern, Central and Volta regions.
Mahama inaugurates Vaccine R&D laboratories, DNA laboratory
FigureMahama inaugurates Vaccine R&D laboratories, DNA laboratory — Adam Bezer / unsplash

Ghana's President John Dramani Mahama has inaugurated Vaccine Research and Development Laboratories and a Human Identification (DNA) Laboratory at the Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, pairing new forensic capacity with a US$1 billion pharmaceutical sector allocation announced at the same ceremony.

The DNA facility exists because of a specific failure. After the military helicopter crash of August 6, 2025, which killed eight eminent Ghanaians, tissue samples recovered from the crash site had to be flown to South Africa for identification, leaving bereaved families waiting for days. "It was a day of shame for Ghana that we couldn't carry out our own DNA analysis in-country," Mahama said. "That will be a thing of the past."

What does the new capacity cover?

The Vaccine R&D Laboratories comprise dedicated vaccine development facilities, including an mRNA Expression Laboratory and a Protein Expression Laboratory. The DNA Laboratory provides domestic infrastructure for human DNA testing and identification, supporting forensic investigations and paternity dispute resolution.

Mahama framed the paternity application in unusually direct terms: "Maternity, we all know, the woman gives birth to the child, so we know the mother. But sometimes the paternity of the father is in dispute, and the laboratory will settle once and for all the questions of who owns the child."

The launch event offered no staffing figures, no equipment specifications and no operational timeline. What the presidency presented is a capacity claim, not a measured output, and the burden now shifts to the institute to demonstrate validated workflows.

Why does the government link this to vaccine security?

Mahama situated the vaccine laboratories within the supply-chain failures exposed by COVID-19, when African countries were, in his words, "the last in the queue" for doses. He noted that West Africa and the wider continent continue to face recurrent threats including Mpox, Lassa fever, Ebola virus disease and Marburg virus disease.

"Preparedness requires foresight, investment and the courage to build capacity before a crisis strikes," he said. The gap between laboratory commissioning and an actual licensed vaccine candidate remains wide, and the government offered no target dates for either.

How does the US$1 billion fit in?

The President announced the allocation under the Seventh Pillar of the New Economy Programme, intended to support pharmaceutical and biomanufacturing hubs in the Eastern, Central and Volta regions. The stated policy goal is to position Ghana as a pharmaceutical manufacturing hub in West Africa, drawing on what Mahama called Ghanaian talent, scientific expertise and local capacity.

The government did not specify how the billion-dollar envelope will be disbursed, over what period, or what share reaches the Noguchi Institute laboratories themselves.

What is the path from bench to production?

Health Minister Kwabena Mintah Akandoh said the new laboratories give Ghanaian scientists the tools to develop vaccine candidates locally. He described a staged pipeline: through collaboration among the National Vaccine Institute, the Food and Drugs Authority and research institutions, Ghana could move from vaccine discovery to clinical trials and ultimately local vaccine production.

Akandoh called the inauguration an important step toward strengthening the country's scientific and health research ecosystem. He offered no trial protocols, regulatory milestones or funding lines for the discovery-to-production sequence, so the pipeline remains a stated intention rather than a scheduled programme.

Mahama also urged the institutions that will rely on the DNA laboratory to communicate promptly and compassionately with affected families, noting that behind every identification request is a family seeking closure. "We must therefore apply the same care to communicating with families as to the scientific work itself," he said.

He added that the commissioning reaffirms the government's determination to build a nation capable of safeguarding its health security, advancing scientific innovation and charting its own path toward prosperity: "I take immense pride in the progress we have made as a nation, and in the bold steps we continue to take to secure a healthier, stronger, more self-reliant future for generations of Ghanaians to come."

The next measurable test will be whether the DNA laboratory handles a national emergency in-country, and whether the mRNA and protein expression facilities advance a vaccine candidate toward trials.

via ghanabusinessnews.com (Source)

Filed under

  • vaccine-research
  • dna-forensics
  • biomanufacturing
  • public-health-funding
  • ghana
Share this article:

More from Amara Osei

Amara Osei

Show full bio

News editor covering money, funding and market shifts around research and development at Hypothesis Wire.

261 articles

References

  1. Ghana Targets First Locally Made Vaccine by Q1 2027
  2. Nigerian Trust in Science Stalls at 15 Per Cent, 11 Points Below 2018
  3. Nigeria demands equity and technology transfer in pandemic preparedness
  4. Ghana urges ITU to target last-mile connectivity as half of Africa stays offline
  5. Lancet Analysis Maps Africa's Vaccine R&D Gaps

« Previous article